Early systemic scleroderma: a current diagnostic algorithm (a lecture)

Early systemic scleroderma: a current diagnostic algorithm (a lecture)

Bibliographic Details
Main Author:	Lidia Petrovna Ananyeva
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2012-04-01
Series:	Научно-практическая ревматология
Online Access:	https://rsp.mediar-press.net/rsp/article/view/1173

Similar Items

NEW CLASSIFICATION CRITERIA FOR SCLERODERMA SYSTEMATICA (a lecture)
by: Lidia Petrovna Ananyeva
Published: (2013-12-01)

Algorithm for the Diagnosis of Scleroderma. Early Systemic Sclerosis: Definitions and diagnostic criteria
by: Domenico Galasso, et al.
Published: (2013-04-01)

Autologous hematopoietic stem cell transplantation for systemic scleroderma
by: R T Alekperov, et al.
Published: (2012-08-01)

Prospects for using mycophenolate mofetil in diffuse scleroderma
by: L P Ananyeva
Published: (2009-03-01)

DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA
by: O. I. Emelyanova, et al.
Published: (2019-05-01)

Diagnosis and treatment of interstitial lung disease in scleroderma systematica
by: L. P. Ananyeva
Published: (2018-06-01)

Lungs intersticial damage and its diagnosis in scleroderma (systemic sclerosis)
by: L V Teplova, et al.
Published: (2008-12-01)

Use of the international systemic scleroderma activity index
by: Maya Nikolayevna Starovoitova, et al.
Published: (2013-03-01)

Interstitial lung disease in systemic sclerosis (systemic scleroderma)
by: L. P. Ananyeva, et al.
Published: (2021-03-01)

Modern methods of a localized scleroderma diagnostics
by: Moiseyev А.А., et al.
Published: (2016-09-01)

Biomarkers in scleroderma: Current status
by: Latika Gupta, et al.
Published: (2017-01-01)

Positivity for antiribonucleoprotein antibodies in rheumatic diseases: focus on scleroderma systematica
by: R. U. Shayakhmetova, et al.
Published: (2018-01-01)

Current therapy of interstitial pneumonia associated with systemic scleroderma
by: L. P. Ananieva
Published: (2020-11-01)

Localized scleroderma – current treatment options
by: Katarzyna Wolska-Gawron, et al.
Published: (2017-12-01)

Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016-11-01)

ULTRASOUND SCANNING: POSSIBILITIES AND PROSPECTS OF EVALUATING LUNG INVOLVEMENT IN SYSTEMIC SCLERODERMA
by: Olga Borisovna Ovsyannikova, et al.
Published: (2012-12-01)

ESOPHAGEAL PATHOLOGY IN SCLERODERMA SYSTEMATICA: CLINICAL AND ENDOSCOPIC FINDINGS
by: A E Karateev, et al.
Published: (2012-02-01)

UNILATERAL LUNG INJURY IN SCLERODERMA SYSTEMATICA: A CASE REPORT
by: R. T. Alekperov, et al.
Published: (2014-09-01)

Treatment for systemic scleroderma
by: Rezvaya Tairovich Alekperov, et al.
Published: (2011-09-01)

Treatment for systemic scleroderma
by: Rezvaya Tairovich Alekperov, et al.
Published: (2011-09-01)

Scleroderma as a paraneoplastic syndrome and tumors associated with scleroderma
by: N. A. Shostak, et al.
Published: (2020-05-01)

Survey of current practice of scleroderma management in India
by: G C Yathish, et al.
Published: (2017-01-01)

Сatalase antibodies in patients with systemic scleroderma as a diagnostic and prognostic marker of the disease
by: O. I. Emelyanova, et al.
Published: (2021-01-01)

Localized scleroderma (morphea). Diagnostic and therapeutic recommendations of the Polish Dermatological Society
by: Dorota Krasowska, et al.
Published: (2019-10-01)

PARANEOPLASTIC SCLERODERMA OR NEOPLASIA SECONDARY TO SCLERODERMA
by: Alexandru Arvunescu, et al.
Published: (2019-12-01)

Keloids in scleroderma-keloidal scleroderma: A unique entity
by: Sumit Sen, et al.
Published: (2013-01-01)

Systemic scleroderma is a multidisciplinary problem
by: N G Guseva, et al.
Published: (2011-04-01)

Brachial artery responsiveness in patients with systemic lupus erythematosus and scleroderma systematica
by: Aleksey Alekseevich Vinogradov, et al.
Published: (2010-03-01)

The problem of activity in systemic scleroderma
by: N G Guseva, et al.
Published: (2013-06-01)

SUBTYPES OF JUVENILE SYSTEMIC SCLERODERMA
by: M N Slarovoitova, et al.
Published: (2001-04-01)

The problem of activity in systemic scleroderma
by: N G Guseva, et al.
Published: (2013-06-01)

THE REAL PREVALENCE OF EROSIVE ESOPHAGITIS AND BARRETT'S ESOPHAGUS IN SYSTEMIC SCLERODERMA: DATA FROM 12-MONTHS PROSPECTIVE STUDY
by: Andrey Evgenievich Karateev, et al.
Published: (2012-10-01)

STUDY OF THE EFFICIENCY AND SAFETY OF MYCOPHENOLATE MOFETIL THERAPY IN PATIENTSWITH SYSTEMIC SCLERODERMA
by: O A Koneva, et al.
Published: (2011-08-01)

RITUXIMAB TREATMENT FOR INTERSTITIAL LUNG INJURY IN SCLERODERMA SYSTEMATICA
by: Lidia Petrovna Ananieva, et al.
Published: (2013-12-01)

Immunological features in anti-U1-ribonucleoprotein antibody positive patients with systemic scleroderma
by: R. U. Shayakhmetova, et al.
Published: (2020-03-01)

Assessment of lung ultrasound in patients with scleroderma systematica and interstitial lung disease
by: Olga Borisovna Ovsyannikova, et al.
Published: (2013-06-01)

EFFECT OF AT ORVASTATIN ON THE TIME COURSE OF CHANGESIN INFLAMMATORY MARKERS IN SYSTEMIC SCLERODERMA
by: R T Alekperov, et al.
Published: (2011-04-01)

Juvenile Localized Scleroderma from the Perspective of Pediatric Rheumatologist. Aspects of Diagnostics
by: Rinat K. Raupov, et al.
Published: (2020-06-01)

Mimics of scleroderma
by: Kaveri K Nalianda, et al.
Published: (2017-01-01)

The pathogenesis of scleroderma
by: Latika Gupta, et al.
Published: (2017-01-01)